期刊文献+

以Ad SIINFEKL—Luc为抗原研究免疫反应的量效关系

Dose-effect relationship between Ad SIINFEKL-Luc immunization and file induced imnmne response
原文传递
导出
摘要 目的定量地探讨腺病毒载体编码的已知抗原与其诱发的抗原特异性细胞免疫反应的量效关系。方法用不同MOI的编码鸡卵清蛋白MHCI多肽SIINFEKL(OVAp257-264)与荧光素(luciferase,Luc)融合蛋白的腺病毒(Ad SIINFEKL-Luc)感染小鼠骨髓来源的树突状细胞(DC),在不同的时间点定量检测DC中Luc的表达;相应地,用表达不同水平SIINFEKL-Luc融合蛋白的DC皮下免疫C57BL/6小鼠,通过体内CTL杀伤试验和细胞内γ干扰素(IFN-γ)染色(ICS)定量分析CTL杀伤活性及其产生IFN-γ的能力。结果Luc在DC中的表达水平与Ad SIINFEKL-Luc所用剂量具有剂量效应关系,AdSIINFEKL-Luc一次感染后在DC中持续4d仍然检测得到Luc的表达。分别用0.1、1、10和100MOI的Ad SIINFEKL-Luc/5×10^5 DC免疫小鼠1周,体内CTL杀伤试验分析小鼠脾细胞4hCTL杀伤率分别是14.4%±2.3%、32.6%±4.5%、86.7%±3.8%和99.8%±0.3%。ICS分析脾脏IFN-γ产生的CD8^+T细胞占总CD8^+T细胞比率分别是0.49%±0.12%、1.74%±0.21%、4.12%±0.34%和9.53%±0.58%。结论Ad SIINFEKL-Luc表达抗原水平的高低与其诱发特异性细胞免疫反应的强弱明显相关。在一定范围内,抗原表达高低与其诱发的抗原特异性细胞免疫反应的强弱呈正相关。 Objective To quantitatively investigate the relationship between a known antigen encoded by adenoviral vector(Ad SIINFEKDLuc) and the induced immune response. Methods Murine bone marrow-derived dendritic cells(DC) were infected by Ad SIINFEKL-Luc encoding a fusion protein consisting of chicken ovalbumin MHC class Ⅰ poptide SIINFEKL(OVAp257-264 ) and luciferase in different MOI and the expression levels of luciferase(Luc) in DC were quantitatively checked. C57BL/6 mice were subcutaneously immunized with the Ad SIINFEKL-Luc-infected DC, and then the killing activity of antigen-specific CTL in spleen were analyzed by in vivo CTL assay and intracellular cytokine staining(ICS) assay for IFN-T produced by antigen-specific CD8^+ T cells were performed. Results A dose-dependent relationship between the levels of Luc expression and doses of Ad SIIN- FEKL-Luc was observed, and the expression of Luc conld be still detected in DC 4 d after Ad SIINFEKD-Luc infection. One week after the subcutaneous immunization of C57BL/6 mice with 0.1, 1, 10 and 100 MOI Ad SIIN- FEKL-Luc × 10^5 DC, the four-hour CTL killing rate were 14.4% ± 2.3%, 32.6% ± 4.5%, 86.7% ± 3.8% and 99.8 % ± 0.3 %, respectively, and the ratio of IFN-γ-producing CD8^+ T cells to total CD8^+ T cells in spleen were 0.49% ±0.12%, 1.74% ±0.21%, 4.12% ±0.34% and 9.53% ±0.58%, respectively. Conclusion There is an obvious relationship between levels of the antigen expressed by Ad SIINFEKL-Luc and antigen-specific cellular immune responses elicited by the antigen. In a certain range, a positive correlation exists.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2007年第3期268-272,共5页 Chinese Journal of Microbiology and Immunology
基金 国家自然科学基金资助项目(30371627) 北京市自然科学基金资助项目(7042062)
关键词 腺病毒载体 树突状细胞 融合蛋白 抗原剂量 免疫反应 Adenoviral vector Dendritic cells Fusion protein Antigen dose Immune response
  • 相关文献

参考文献12

  • 1Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature, 1998, 392(6673): 245-252.
  • 2Lutz MB, Kukutsch N, Ogilvie AL, et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods, 1999, 223(1): 77-92.
  • 3谭晓华,万永红.异种黑色素瘤相关抗原诱发抗肿瘤免疫伴发自身免疫性损伤[J].中华医学杂志,2005,85(23):1596-1600. 被引量:11
  • 4Coles RM, Mueller SN, Heath WR, et al. Progression of armed CTL from draining lymph node to spleen shortly after localized infection with herpes simplex virus 1. J Immunol, 2002, 168(2) : 834-838.
  • 5Morelli AE, Larregina AT, Ganster RW, et al. Recombinant adenovirus induces maturation of dendritic cells via an NF-kappaB-dependent pathway. J Virol, 2000, 74(20): 9617-9628.
  • 6Hirschowitz EA, Weaver JD, Hidalgo GE, et al. Murine dendritic cells infected with adonovirus vectors show signs of activation. Gone Ther, 2000, 7(13): 1112-1120.
  • 7Schumacher L, Ribas A, Dissette VB, et al. Human dendritic cell maturation by adenovirus transduction enhances tumor antigen-specific T-cell responses. J Immunother, 2004, 27(3): 191-200.
  • 8Kurts C, Miller JF, Subramaniam RM, et al. Major histocompatibility complex class Ⅰ-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction. J Exp Med, 1998, 188(2): 409-414.
  • 9Constant SL, Bottomly K. Induction of Th1 and Th2 CD4^+ T cell responses: the alternative approaches. Annu Rev Immunol, 1997, 15:297-322.
  • 10Hosken NA, Shibuya K, Heath AW, et al. The effect of antigen dose on CD4^+ T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model. J Exp Med, 1995, 182(5) : 1579-1584.

二级参考文献15

  • 1Wang RF, Appella E, Kawakami Y, et al. Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes. J Exp Med, 1996, 184:2207-2216.
  • 2Bloom MB, Perry-Lalley D, Robbins PF, et al. Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma. J Exp Med, 1997, 185:453-459.
  • 3Parkhurst MR, Fitzgerald EB, Southwood S, et al. Identification of a shared HLA-A * 0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). Cancer Res, 1998,58:4895-4901.
  • 4Wang RF, Johnston SL, Southwood S, et al. Recognition of an antigenic peptide derived from tyrosinase-related protein-2 by CTL in the context of HLA-A31 and -A33. J Immunol, 1998,160:890 -897.
  • 5Sun Y, Song M, Stevanovic S, et al. Identification of a new HLA-A( * )0201-restricted T-cell epitope from the tyrosinase-related protein 2 (TRP2) melanoma antigen. Int J Cancer, 2000, 87:399-404.
  • 6Noppen C, Levy F, Burri L, et al. Naturally processed and concealed HLA-A2. 1-restricted epitopes from tumor-associated antigen tyrosinase-related protein-2. Int J Cancer, 2000, 87:241-246.
  • 7Coles RM, Mueller SN, Heath WR, et al. Progression of armed CTL from draining lymph node to spleen shortly after localized infection with herpes simplex virus 1. J Immunol, 2002, 168: 834-838.
  • 8Pardoll D. Does the immune system see tumors as foreign or self?Annu Rev Immunol, 2003, 21:807-839.
  • 9Pardoll DM. Inducing autoimmune disease to treat cancer. Proc Natl Acad Sci U S A, 1999, 96:5340-5342.
  • 10Wei YQ, Wang QR, Zhao X, et al. Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine. Nat Med, 2000, 6:1160-1166.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部